Aisaiti Aikebaierjiang, Aierxiding Shalayiding, Shoukeer Kutiluke, Muheremu Aikeremujiang
Key Laboratory of Orthopedic Regenerative Medicine, Sixth Affiliated Hospital of Xinjiang Medical University, Ürümqi, Xinjiang, China.
Beijing Darwin Cell Biotechnology Co., Ltd., Beijing, China.
Front Neurol. 2024 Aug 5;15:1420402. doi: 10.3389/fneur.2024.1420402. eCollection 2024.
To use bibliometric methods to analyze the research hotspots and future development trends regarding the application of mesenchymal stem cells in peripheral nerve injury and regeneration.
Articles published from January 1, 2013, to December 31, 2023, were meticulously screened using the MeSH terms: TS = ("Mesenchymal stem cells" AND "Peripheral nerve injury") OR TS = ("Mesenchymal stem cells" AND "Peripheral nerve regeneration") within the Web of Science database. The compiled data was then subjected to in-depth analysis with the aid of VOSviewer and Cite Space software, which facilitated the identification of the most productive countries, organizations, authors, and the predominant keywords prevalent within this research domain.
An extensive search of the Web of Science database yielded 350 relevant publications. These scholarly works were authored by 2,049 collaborative researchers representing 41 countries and affiliated with 585 diverse academic and research institutions. The findings from this research were disseminated across 167 various journals, and the publications collectively cited 21,064 references from 3,339 distinct journals.
Over the past decade, there has been a consistent upward trajectory in the number of publications and citations pertaining to the use of mesenchymal stem cells in the realm of peripheral nerve injury and regeneration. The domain of stem cell therapy for nerve injury has emerged as a prime focus of research, with mesenchymal stem cell therapy taking center stage due to its considerable promise in the treatment of nerve injuries. This therapeutic approach holds the potential to significantly enhance treatment options and rehabilitation prospects for patients suffering from such injuries.
运用文献计量学方法分析间充质干细胞在周围神经损伤与再生应用方面的研究热点及未来发展趋势。
在Web of Science数据库中，使用主题词：TS =（“间充质干细胞” AND “周围神经损伤”）或TS =（“间充质干细胞” AND “周围神经再生”），精心筛选2013年1月1日至2023年12月31日发表的文章。然后借助VOSviewer和Cite Space软件对汇总的数据进行深入分析，以确定该研究领域中发文量最多的国家、机构、作者以及主要的关键词。
对Web of Science数据库进行广泛检索后获得350篇相关出版物。这些学术著作由来自41个国家的2049名合作研究人员撰写，他们隶属于585个不同的学术和研究机构。该研究的结果发表在167种不同的期刊上，这些出版物共引用了来自3339种不同期刊的21064篇参考文献。
在过去十年中，间充质干细胞在周围神经损伤与再生领域的出版物数量和引用次数一直呈上升趋势。神经损伤的干细胞治疗领域已成为主要研究焦点，间充质干细胞治疗因其在治疗神经损伤方面具有巨大潜力而占据核心地位。这种治疗方法有可能显著增加此类损伤患者的治疗选择和康复前景。
